The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice

Medical Science Monitor

Volumn 17, Issue 12, 2011, Pages

  Lai, Hoang M ^a   Aronow, Wilbert S ^a   Mercando, Anthony D ^b   Kalen, Phoenix ^a   Desai, Harit V ^a   Gandhi, Kaushang ^a   Sharma, Mala ^a   Amin, Harshad ^a   Lai, Trung M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

Coronary revascularization; Myocardial infarction; Statins

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID SEQUESTRANT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; EZETIMIBE; FIBRIC ACID DERIVATIVE; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NICOTINIC ACID; NITRATE; SITAGLIPTIN; SULFONYLUREA DERIVATIVE; TICLOPIDINE; WARFARIN;

AGED; CARDIOLOGY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT; OUTPATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; TREATMENT OUTCOME;

EID: 82755165771     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882126     Document Type: Review

References (36)

1. Miettinen TA, Pyorala K, Olsson AG et al: Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Findings from the Scandinavian Simvastatin Survival Study (4S). Circulation, 1997; 96: 4211-18
2. Lewis SJ, Moye LA, Sacks FM et al: Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) Trial. Ann Intern Med, 1998; 129: 681-89
3. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998; 339: 1349-57
4. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 2002; 360: 7-22
5. Cannon CP, Braunwald E, McCabe CH et al: Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med, 2004; 350: 1495-504
6. LaRosa JC, Grundy SM, Waters DD et al: Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Eng J Med, 2005; 352: 1425-35
7. Aronow WS, Ahn C: Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering drug. Am J Cardiol, 2002; 89: 67-69
8. Szadkowska I, Stanczyk A, Aronow WS et al: Statin therapy in the elderly: a review. Arch Gerontol Geriatr, 2010; 50: 114-18
9. Mercando AD, Lai HM, Aronow WS et al: Reduction in atherosclerotic events through use of aggressive risk factor reduction medications: a retrospective study in an outpatient cardiology practice. Arch Med Sci, 2012; (in press)
10. Lai HM, Aronow WS, Rachdev A et al: Incidence of mortality in 1,040 patients with coronary heart disease or hypertensive heart disease with normal and abnormal left ventricular ejection fraction and with normal and abnormal QRS duration. Arch Med Sci, 2008; 4: 140-42
11. Ramdeen N, Aronow WS, Chugh S, Asija A: Patients undergoing coronary angiography because of chest pain with hepatitis C virus have a higher prevalence of obstructive coronary artery disease than a control group. Arch Med Sci, 2008; 4: 452-54
12. Kannam H, Aronow WS, Chilappa K et al: Association of the QRS duration on the resting electrocardiogram with the severity of coronary artery disease in 2,196 patients undergoing coronary angiography for suspected coronary artery disease. Arch Med Sci, 2009; 5: 163-65
13. 2 determined by intravascular ultrasound in patients with coronary artery calcium scores of 0-100, 100-200, 200-300, 300-400, and >400 determined by cardiac computer tomography. Arch Med Sci, 2009; 5: 172-74
14. Shen X, Aronow WS, Nair CK et al: Thoracic aortic atheroma severity predicts high-risk coronary anatomy in patients undergoing transesophageal echocardiography. Arch Med Sci, 2011; 7: 61-66
15. Aronow WS: Osteoporosis, osteopenia, and atherosclerotic vascular disease. Arch Med Sci, 2011; 7: 21-26
16. Duncan KA, Sukhija R, Aronow WS et al: Systolic compression of left main coronary artery by left ventricular pseudoaneurysm complicated by critical stenosis. Arch Med Sci, 2012; (in press)
17. Angelopoulos J, Krassakopoulos N, Nathanson R et al: Co-administration of ezetimibe and a statin in management of dyslipidemias: a meta-analysis of clinical trials. Arch Med Sci, 2009; 5: 347-63
18. Delavari A, Kelishadi R, Forouzanfar MH et al: The first cut-off points for generalized and abdominal obesity in predicting lipid disorders in a nationally representative population in the Middle East: The National Survey of Risk Factors for Non-Communicable Diseases of Iran. Arch Med Sci, 2009; 5: 542-49
19. Diakou M, Miltiadous G, Xenophontos S et al: Characterization of low density lipoprotein receptor (LDLR) gene mutations in Albania. Arch Med Sci, 2010; 6: 198-200
20. Gordon L, Ragoobirsingh D, Morrison E et al: Dyslipidemia in hypertensive obese type 2 diabetic patients in Jamaica. Arch Med Sci, 2010; 6: 701-8
21. Katsiki N, Mikhailidis DP, Athyros VG et al: Are we getting to lipid targets in real life? Arch Med Sci, 2010; 6: 639-41
22. Mark L, Paragh G, Karadi I et al: Changes in attainment of lipid goals by general practitioners and specialists in patients at high cardiovascular risk in Hungary during 2004-2008. Arch Med Sci, 2010; 6: 695-700
23. Pavlidis AN, Kolovou GD, Anagnostopoulou KK et al: Postprandial metabolic heterogeneity in men with primary dyslipidaemia. Arch Med Sci, 2010; 6: 879-86
24. Ravipati G, Aronow WS, Kumbar S et al: Patients with diabetes with ischemic stroke have a higher hemoglobin A1c level and a higher serum low-density lipoprotein cholesterol level than diabetics without ischemic stroke. Arch Med Sci, 2009; 5: 391-93
25. Vulic D, Loncar S, Krneta M et al: Risk factor control and adherence to treatment in patients with coronary heart disease in the Republic of Srpska, Bosnia and Herzegovina in 2005-2006. Arch Med Sci, 2010; 6: 270-75
26. Wainwright G, Mascitelli L, Goldstein MR: Cholesterol-lowering therapy and cell membranes. Stable plaque at the expense of unstable membranes? Arch Med Sci, 2009; 5: 289-95
27. Wozniak B, Wozniak A, Drewa G et al: The effect of treatment on lipid peroxidation in patients with subarachnoid haemorrhage. Arch Med Sci, 2009; 5: 394-400
28. Xu M, Yuan G, Wei F: Effect of atorvastatin in patients with chronic heart failure-insights from randomized clinical trials. Arch Med Sci, 2010; 6: 866-73
29. Haleagrahara N, Yee TM, Chakravarthi S, Lee N: Protective effect of N-acetylcysteine on cyclosporine A-induced changes in lipid hydroperoxide levels and renal dysfunction in rats. Arch Med Sci, 2009; 5: 16-22
30. Kedziora-Kornatowska K, Czuczejko J, Motyl J et al: Effects of coenzyme Q10 supplementation on activities of selected antioxidative enzymes and lipid peroxidation in hypertensive patients treated with indapamide. A pilot study. Arch Med Sci, 2010; 6: 513-18
31. Mujib M, Desai R, Levitan EB et al: Prospective population studies of incident heart failure without data on baseline left ventricular ejection fraction. Arch Med Sci, 2010; 6: 686-88
32. Katsiki N, Mikhailidis DP, Banach M: Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels. J Hypertens, 2011; 29: 2493-94
33. Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J: Time for new indications for statins? Med Sci Monit, 2009; 15(12): MS1-5
34. Stepien M, Banach M, Mikhailidis DP et al: Role and significance of statins in the treatment of hypertensive patients. Curr Med Res Opin, 2009; 25: 1995-2005
35. Desai H, Aronow WS, Ahn C et al: Incidence of perioperative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins. Arch Gerontol Geriatr, 2010; 51: 149-51
36. Aronow HD, Hess G, Hill J et al: Switching from atorvastatin to simivastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol. Am J Therap, 2010; 17: 167-75